Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DNA Methylation Biomarkers for Cervical Cancer Screening

NCT02605941 is registered in ClinicalTrials.gov with iStat Biomedical CO., Ltd. as lead sponsor.

NCT NCT02605941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02605941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DNA Methylation Biomarkers for Cervical Cancer Screening
Lead sponsor
iStat Biomedical CO., Ltd.
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2014
Completion date
August 31, 2016
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, cervical intraepithelial neoplasia